In multicellular organisms, cells communicate with each other via extracellular molecules such as nucleotides, lipids, short peptides, or proteins. These molecules are released in the extracellular space to bind to receptors on other cells, thus modifying intracellular signaling in the recipient cells. In addition to these single molecules, cells also release in their extracellular environment a series of complex structures called membrane vesicles, which contain numerous proteins, lipids, and even nucleic acids 1 . Although known for several decades to exist, membrane vesicles have long been thought of as mere cell debris. Over the past few years, however, accumulated evidence has shown that vesicles can affect the cells they encounter by acting as signaling vehicles containing a cell-specific cargo of proteins, lipids, and genetic material that are moved to other cells where they alter function and physiology. The topic of extracellular vesicle-mediated cell-cell communication has now blossomed into a full-fledged field of research.
The three main populations of extracellular vesicles are commonly classified based on their intracellular origin: apoptotic bodies (50 nm-5 μm in size, include DNA, RNA, and histones, and display surface markers, causing them to be rapidly cleared by macrophages), microparticles (50-1000 nm in size, also referred to as microvesicles, ectosomes, shedding vesicles, microparticles, plasma membrane-derived vesicles, or exovesicles), and exosomes.
Exosomes are 40-100 nm in size and represent a specific subtype of secreted membrane vesicles formed through the fusion of multivesicular endosomes with the plasma membrane 2 .
The endosomal system controls the uptake and processing of various types of macromolecules Although originally described in 1983 by Harding et al. 3 , exosomes received little attention until the discovery of their ability to modulate the immune system 4 , and their potential to transfer genetic information due to the presence of mRNA and miRNA 5 . Since then, the multiple functions of exosomes in immune modulation 6 , tumorigenesis 7 , and propagation of neurodegenerative disease 8 have become evident. This has sparked interest in exosomes as biomarkers and therapeutic targets.
In this issue of Circulation, Lee and colleagues 9 explore the therapeutic potential of mesenchymal stromal cell (MSC)-derived exosomes for the prevention of hypoxia-induced pulmonary hypertension in mice. The rationale is based on previous studies where engraftment and direct tissue repair was not necessarily required for MSC therapeutic function, but that paracrine mechanisms accounted for much of the therapeutic benefit of MSCs 10 . These studies revealed that a single injection of cell-free conditioned media derived from MSC exerted longlasting therapeutic effects 11 .
In the current study 9 , the authors fractionated mouse and human cord MSC-conditioned media and show that the biologically-active component includes exosomes. MSC-derived exosomes (MEX) had pleitropic effects and attenuated lung macrophage influx, as well as decreased pro-inflammatory cytokine levels in the bronchoalveolar lavage. This was associated with prevention of pulmonary vascular remodeling and hypoxic-induced pulmonary hypertension in the mice studied. Fibroblast-derived exosomes and MEX-depleted media had no biomarkers and therapeutic targets.
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More interestingly, and in accordance with previous exosome literature 5 , MEX suppressed the hypoxic activation of STAT3 and upregulation of the miR-17 superfamily of microRNA clusters, whereas it increased lung levels of miR-204, a microRNA recently shown to be decreased in human pulmonary hypertension.
Thus, Lee and colleagues provide the first demonstration of the therapeutic potential of MSC-derived exosomes for pulmonary hypertension 9 . Their findings open exciting avenues given the relevance for other multi-factorial diseases. Indeed, the discovery of the paracrine effect of stem cells has led to the identification of a variety of bioactive molecules secreted by MSCs 12 . Each of these may contribute to the therapeutic benefit, but it is more likely the combination of these molecules that provide the compounding pleiotropic effects attributed to
MSCs. However, the opportunity to capitalize on "cell-based therapies without the cell" brings with it an enormous challenge, such as the need to identify all of the bioactive molecules and determine which combination is most effective. Exosomes are ideal therapeutic agents because their complex cargo of proteins and genetic material has the diversity and biochemical potential to participate in multiple biochemical and cellular processes, a key attribute in the treatment of complex diseases 13, 14 .
One important challenge in studying exosomes is the lack of robust, reproducible isolation in order to obtain highly pure and well-characterized vesicular populations. Thus far, three different methods have been proposed to isolate and characterize exosomes: (i) ultracentrifugation 15 , (ii) ultrafiltration 16 , and (iii) immunoprecipitation technologies using antibody-loaded magnetic cell beads 17 . Only electron microscopy allows detailed visualization of exosomes making it difficult to assess their function in vivo 18 . Exosomes float on a sucrose MSCs 12 . Each of these may contribute to the therapeutic benefit, but it is more li lik ke kely ly ly t t the he he combination of these molecules that provide the compounding pleiotropic effects attributed to MS MS SCs Cs Cs. . Ho Ho Howe we wever, r, r t t th he opportunity to capitalize o on n n "c cell-based ther r rap a a ie es s s w wi without the cell" brings w with h h it an enorm rmou ou us ch ch c al al lle le leng ng nge, e e, s su uch ch ch a as s s t th he n n nee e ed to o o i iden n nt ti ify fy y all ll l o of f f t th he e bi bi bioa a act ctiv iv ive e e mo mo ole lecu cu c le l l s s s an and d
de dete te term rm min ine e wh wh whic ich h h c co omb mb bin in nat atio on n n is is is m m mo os ost t ef ef effe fe fect ct ctiv v ve. e. e E Exo osom omes es are re e id deal al t the hera rape peut utic ic a age ge ents s be eca aus use e heir comple ex x ca carg rgo o of of p pro ote tein ins an and d ge gene neti tic c ma ma ate teri rial al h has as s t the he d div iver e si i s ty ty an and d bi bi ioc oche hemi mica cal potential density gradient at heights of 1.13-1.19 g/mL, and contain specific proteins that are incorporated during the formation process in multivesicular bodies, such as Alix, TSG101, and tetraspanins (CD9, CD63), which are frequently used as identification markers. However, there is a current lack of consensus as to the optimal methods for the isolation of pure vesicular preparations. This situation is reminiscent of the MSC field before the description of the minimal criteria for defining multipotent mesenchymal stromal cells, although knowledge about MSCs is still evolving 19 .
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